{
    "meta": {
        "portal_name": "pharmacokinetics",
        "language": "en",
        "updated": "20150502"
    },
    "schema": {
        "html:portal": "http://en.recuweb.com/pharmacokinetics/",
        "graph:videos": "http://en.recuweb.com/graph/v1.0/pharmacokinetics/pharmacokinetics/videos.json",
        "graph:news": "http://en.recuweb.com/graph/v1.0/pharmacokinetics/pharmacokinetics/news.json",
        "graph:blogs": "http://en.recuweb.com/graph/v1.0/pharmacokinetics/pharmacokinetics/blogs.json"
    },
    "items": {
        "marketwired.com/2015/04/critical-outcome-technologies-files-investigational-new-drug-application-with-the-fda": {
            "title": "Critical Outcome Technologies Files Investigational New Drug Application With the FDA for COTI-2...",
            "snippet": "The IND application is a complete description of the chemistry, non-clinical pharmacodynamics and pharmacokinetics, safety toxicology, manufacturing and other relevant information related to COTI-2 as a potential treatment for patients with p53...",
            "date": "2015-04-27",
            "categories": "toxicology,chemistry,pharmacodynamics,pharmacokinetics",
            "tags": "treatment,patients,information,related,safety,drug,fda,clinical,pharmacodynamics,pharmacokinetics",
            "recuweb_url": "http://en.recuweb.com/pharmacokinetics/marketwired.com/2015/04/critical-outcome-technologies-files-investigational-new-drug-application-with-the-fda",
            "resource_url": "http://www.bing.com/news/search?first=1&q=pharmacokinetics&format=RSS&cc=us",
            "source_url": "http://marketwired.com/press-release/critical-outcome-technologies-files-investigational-new-drug-application-with-fda-coti-tsx-venture-cot-2013503.htm"
        },
        "anesthesiologynews.com/2015/04/postoperative-pain-management-in-anorectal-surgery-anesthesiology-news": {
            "title": "Postoperative Pain Management in Anorectal Surgery - Anesthesiology News...",
            "snippet": "Anesthesiology NewsPostoperative Pain Management in Anorectal SurgeryAnesthesiology NewsThe pharmacokinetics result in a sevenfold increase in the T max, and a 9.8 times increase in the half-life of the medication. The manufacturer states that the...",
            "date": "2015-04-27",
            "categories": "life,surgery,management,pharmacokinetics",
            "tags": "pharmacokinetics",
            "recuweb_url": "http://en.recuweb.com/pharmacokinetics/anesthesiologynews.com/2015/04/postoperative-pain-management-in-anorectal-surgery-anesthesiology-news",
            "resource_url": "http://news.google.com/?hl=en&q=pharmacokinetics&output=atom&nord=1",
            "source_url": "http://anesthesiologynews.com/ViewArticle.aspx?d=Clinical+Anesthesiology&d_id=1&i=March+2014&i_id=1045&a_id=26086&tab=RecentComments"
        },
        "empr.com/2015/04/rare-facial-disorder-drug-designated-orphan-status": {
            "title": "Rare Facial Disorder Drug Designated Orphan Drug Status...",
            "snippet": "RELATED: Musculoskeletal Disorders Resource Center Resolaris is currently being studied in a Phase 1b/2, randomized, double-blind, placebo-controlled trial designed to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of...",
            "date": "2015-04-27",
            "categories": "pharmacokinetics",
            "tags": "immunogenicity,trial,designed,designed-to-evaluate,evaluate,evaluate-the-safety,safety,resolaris,rare,drug,orphan,orphan_drug,related,phase,tolerability,pharmacokinetics",
            "recuweb_url": "http://en.recuweb.com/pharmacokinetics/empr.com/2015/04/rare-facial-disorder-drug-designated-orphan-status",
            "resource_url": "http://www.bing.com/news/search?first=1&q=pharmacokinetics&format=RSS&cc=us",
            "source_url": "http://empr.com/rare-facial-disorder-drug-designated-orphan-drug-status/article/411195/"
        },
        "streetinsider.com/2015/04/tetraphase-pharma-ttph-announces-eravacycline-phase-3-met-primary": {
            "title": "Tetraphase Pharma (TTPH) Announces Eravacycline Phase 3 Met Primary... -...",
            "snippet": "Tetraphase Pharma (TTPH) Announces Eravacycline Phase 3 Met Primary... pharmacokinetics for both oral doses of eravacycline were comparable to the IV formulation. The spectrum of pathogens in this trial was similar to that seen in other pivotal...",
            "date": "2015-04-27",
            "categories": "pharmacokinetics",
            "tags": "trial,doses,phase,pharma,pharmacokinetics",
            "recuweb_url": "http://en.recuweb.com/pharmacokinetics/streetinsider.com/2015/04/tetraphase-pharma-ttph-announces-eravacycline-phase-3-met-primary",
            "resource_url": "http://news.google.com/?hl=en&q=pharmacokinetics%2Bpharmacokinetics&output=atom&nord=1",
            "source_url": "http://streetinsider.com/Corporate+News/Tetraphase+Pharma+(TTPH)+Announces+Eravacycline+Phase+3+Met+Primary+Endpoint/10490258.html"
        },
        "bizjournals.com/2015/04/atyr-pharma-receives-u-s-fda-orphan-designation-for-resolaris": {
            "title": "aTyr Pharma Receives U.S. FDA Orphan Designation for Resolaris...",
            "snippet": "The trial is designed to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of multiple intravenous doses of Resolaris in adult patients with FSHD. FSHD is a severe, rare genetic myopathy with an immune component for which there...",
            "date": "2015-04-27",
            "categories": "pharmacokinetics",
            "tags": "rare,adult,adult-patients,patients,immunogenicity,immunogenicity-of-multiple,multiple,multiple-intravenous,multiple-intravenous-doses,intravenous,intravenous-doses,doses,trial,trial-is-designed,designed,designed-to-evaluate,evaluate,evaluate-the-safety,safety,fda,fda_orphan,orphan,designation,atyr,pharma,resolaris,tolerability,pharmacokinetics,fshd",
            "recuweb_url": "http://en.recuweb.com/pharmacokinetics/bizjournals.com/2015/04/atyr-pharma-receives-u-s-fda-orphan-designation-for-resolaris",
            "resource_url": "http://www.bing.com/news/search?first=1&q=pharmacokinetics&format=RSS&cc=us",
            "source_url": "http://bizjournals.com/prnewswire/press_releases/2015/04/27/NE90551"
        },
        "news-medical.net/2015/04/atyr-s-resolaris-granted-fda-orphan-drug-designation-for-treatment-of": {
            "title": "aTyr's Resolaris granted FDA Orphan Drug Designation for treatment of FSHD -...",
            "snippet": "aTyr's Resolaris granted FDA Orphan Drug Designation for treatment of trial is designed to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of multiple intravenous doses of Resolaris in adult patients with FSHD. FSHD is a...",
            "date": "2015-04-27",
            "categories": "pharmacokinetics",
            "tags": "adult,adult-patients,patients,immunogenicity,immunogenicity-of-multiple,multiple,multiple-intravenous,multiple-intravenous-doses,intravenous,intravenous-doses,doses,treatment,trial,trial-is-designed,designed,designed-to-evaluate,evaluate,evaluate-the-safety,safety,fda,fda_orphan,orphan,orphan_drug,drug,designation,atyr,resolaris,fshd,tolerability,pharmacokinetics",
            "recuweb_url": "http://en.recuweb.com/pharmacokinetics/news-medical.net/2015/04/atyr-s-resolaris-granted-fda-orphan-drug-designation-for-treatment-of",
            "resource_url": "http://news.google.com/?hl=en&q=pharmacokinetics%2Bpharmacokinetics&output=atom&nord=1",
            "source_url": "http://news-medical.net/news/20150427/aTyrs-Resolaris-granted-FDA-Orphan-Drug-Designation-for-treatment-of-FSHD.aspx"
        },
        "biomedcentral.com/2015/04/local-pelvic-irradiation-modulates-pharmacokinetics-of-5-fluorouracil-in-the-plasma": {
            "title": "Local pelvic irradiation modulates Pharmacokinetics of 5-Fluorouracil in the plasma but not in the...",
            "snippet": "Corresponding authors: Tung-Hu Tsai - Yu-Jen Chen 2 Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan 3 Department of Medicine, School of Medicine, National Yang-Ming University, Taipei...",
            "date": "2015-04-25",
            "categories": "university,medicine,pharmacokinetics,institute,school",
            "tags": "pharmacokinetics,school",
            "recuweb_url": "http://en.recuweb.com/school/biomedcentral.com/2015/04/local-pelvic-irradiation-modulates-pharmacokinetics-of-5-fluorouracil-in-the-plasma",
            "resource_url": "http://www.bing.com/news/search?first=1&q=pharmacokinetics&format=RSS&cc=us",
            "source_url": "http://biomedcentral.com/1471-2407/15/316/abstract"
        },
        "rttnews.com/2015/04/regulus-therapeutics-presents-new-data-strengthening-profile-of-rg-101": {
            "title": "Regulus Therapeutics Presents New Data Strengthening Profile Of RG-101...",
            "snippet": "Regulus noted that it also made several poster presentations highlighting the pharmacokinetics and pharmacodynamics of RG-101 in healthy volunteers, the preclinical pharmacokinetics, pharmacodynamics, and toxicity of RG-101, and the efficacy of...",
            "date": "2015-04-25",
            "categories": "pharmacokinetics,pharmacodynamics",
            "tags": "data,pharmacokinetics,pharmacodynamics",
            "recuweb_url": "http://en.recuweb.com/pharmacodynamics/rttnews.com/2015/04/regulus-therapeutics-presents-new-data-strengthening-profile-of-rg-101",
            "resource_url": "http://www.bing.com/news/search?first=1&q=pharmacokinetics&format=RSS&cc=us",
            "source_url": "http://rttnews.com/2487502/regulus-therapeutics-presents-new-data-strengthening-profile-of-rg-101.aspx"
        },
        "thestreet.com/2015/04/basilea-reports-isavuconazole-and-ceftobiprole-data-to-be-presented-at-eccmid": {
            "title": "Basilea Reports Isavuconazole And Ceftobiprole Data To Be Presented At ECCMID...",
            "snippet": "In addition, pharmacokinetics, safety and tolerability of high-dose ceftobiprole in the intensive care setting are being presented. HAP is one of the most common infectious diseases acquired in hospitals, affecting% of hospitalized patients.",
            "date": "2015-04-23",
            "categories": "infectious-diseases,pharmacokinetics",
            "tags": "patients,safety,tolerability,data,pharmacokinetics",
            "recuweb_url": "http://en.recuweb.com/pharmacokinetics/thestreet.com/2015/04/basilea-reports-isavuconazole-and-ceftobiprole-data-to-be-presented-at-eccmid",
            "resource_url": "http://www.bing.com/news/search?first=1&q=pharmacokinetics&format=RSS&cc=us",
            "source_url": "http://thestreet.com/story/13125060/1/basilea-reports-isavuconazole-and-ceftobiprole-data-to-be-presented-at-eccmid.html"
        },
        "uml.edu/2015/04/announcing-new-dean-of-school-pharmacy-and-pharmaceutical-sciences": {
            "title": "Announcing New Dean of School of Pharmacy and Pharmaceutical Sciences...",
            "snippet": "As an educator, he designed and delivered courses such as drug discovery and development, biopharmaceutics and pharmacokinetics, and toxicokinetics. He has written two books as sole author in pharmacokinetics and toxicokinetics. UMass Lowell's...",
            "date": "2015-04-21",
            "categories": "school,pharmacokinetics",
            "tags": "written,biopharmaceutics,discovery,development,designed,school,drug,pharmacokinetics",
            "recuweb_url": "http://en.recuweb.com/pharmacokinetics/uml.edu/2015/04/announcing-new-dean-of-school-pharmacy-and-pharmaceutical-sciences",
            "resource_url": "http://www.bing.com/news/search?first=1&q=pharmacokinetics&format=RSS&cc=us",
            "source_url": "http://uml.edu/Today/Submissions/2015/2015-04-21-07-58-32-Announcing-New-Dean-of-Pharmacy-and.aspx"
        }
    }
}